Primary outcomes and characteristics of clinical trial registries (up to October 2021) on COVID‐19 vaccines

Ähnliche Einträge

• Risk of Bias Assessment of Randomized Controlled Trials: From the 1994 Cochrane Collaboration Toolkit to ROBUST‐RCT
  von: Rafael Leite Pacheco, et al.
  Veröffentlicht: (2025)
• Reasons for Downgrading the Certainty of Evidence for Indirectness in Synthesis of Surgical Procedures for Patients With Fractures: A Meta‐Research Analysis
  von: Julia Pozzetti Daou, et al.
  Veröffentlicht: (2025)
• How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID‐19 vaccines
  von: Raphael Lataster
  Veröffentlicht: (2024)
• RETRACTION: “Re: How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID‐19 vaccines”
  Veröffentlicht: (2024)
• RETRACTED: Re: How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID‐19 vaccines
  von: Hinpetch Daungsupawong, et al.
  Veröffentlicht: (2024)